Quantcast

Latest Vaccines Stories

2014-03-12 08:29:43

BEIJING, March 12, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the fourth quarter and whole year ended December 31, 2013, after market closes on Wednesday, March 19, 2014 EDT. The Company will host a conference call prior to the market opening on Thursday, March 20, 2014, at 8:00 a.m. EDT (Thursday, March 20, 2014 at 8:00 p.m. China Standard...

2014-03-12 04:21:10

BLUE BELL, Pa., March 12, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it will host a conference call and live webcast to report its fourth quarter and year end 2013 financial results on Monday, March 17, 2014 at 8:30 a.m. ET. Management will provide an update on the company, discuss fourth quarter and year end results, and discuss expectations for 2014. The audio presentation will be broadcast online at...

2014-03-11 23:04:38

New studies from Bioradar UK Ltd. and Replikins Ltd show that Pancreatic Cancer Joins Brain and Lung Cancer with the Highest Human Mortality Rates and Gene Replikin Counts; Thirty Times Greater Than the Gene Replikin Counts in H1N1 Influenza. LONDON, UK (PRWEB) March 11, 2014 Bioradar UK Ltd. and Replikins Ltd, the companies whose software analysis of virus gene Replikin Counts predicted the H1N1 influenza pandemic of 2009 one year in advance, announced today that their new studies show...

2014-03-10 23:23:05

GIA announces the release of a comprehensive global report on Veterinary Vaccines markets. Global market for Veterinary Vaccines is forecast to reach US$9.0 billion by 2020, buoyed by resurgence in global trade, emerging pet industry in the developing countries, increased animal movement and the subsequent emergence of animal diseases. San Jose, California (PRWEB) March 10, 2014 Fueled by the high prevalence of diseases in livestock herds and pets, and the continuous emergence of newer...

2014-03-10 23:01:02

Scientific Technologies Corporation (STC) published its 2013 Public Health Annual Report. STC is staying true to its mission to ensure healthy populations through partnerships, expertise, and applied use of information technology. Scottsdale, Arizona (PRWEB) March 10, 2014 Scientific Technologies Corporation (STC), entering its 26th year of providing public health information technology products and services, published its 2013 Public Health Annual Report that summarizes a year of...

2014-03-10 16:32:39

RNActive® Vaccines Offer Excellent Conditions for Cost-Effective Worldwide Distribution TUBINGEN, Germany and BRUSSELS, March 10, 2014 /PRNewswire/ -- CureVac, a German clinical stage biopharmaceutical company, today announced that it has won the inaugural European Commission Vaccine Prize. The EU has dedicated the prize of two million Euros in an effort to stimulate innovative solutions for vaccine transportation and storage where cold chain cannot be guaranteed. CureVac's...

2014-03-06 12:26:41

DUBLIN, Mar, 06, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/dwqqfq/research_report ) has announced the addition of the "Concise Analysis of the International and Chinese Human Vaccine Industry" report to their offering. (Logo:http://photos.prnewswire.com/prnh/20130307/600769) The research object of the report is human vaccines. According to different types and sources, vaccines can be divided into pathogenic protein vaccine, recombinant protein...

2014-03-04 12:25:30

BLUE BELL, Pa., March 4, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) ("Inovio" or the "Company"), today closed its previously announced underwritten public offering of 21,810,900 shares of the Company's common stock, including 2,844,900 shares of common stock issued pursuant to the underwriter's exercise of its overallotment option, at the public offering price of $2.90 per share. The gross proceeds of this offering were approximately $63.3 million. Net proceeds...

2014-03-03 04:22:47

ZEIST, The Netherlands, March 3, 2014 /PRNewswire/ -- Upgrade to BSL-3 level answers growing global demand for testing facilities Introduction of a Bio Safety Level 3 (BSL-3) facility and development of special techniques allow Dutch TNO Triskelion to test vaccines against deadly viruses like avian flu and SARS. With this step the contract research organisation responds to a globally growing demand for testing facilities for the development of drugs against these...

2014-03-03 00:21:43

LYON, France, March 3, 2014 /PRNewswire/ -- - Sanofi Pasteur works with global partners to make available unparalleled quantities of affordable Inactivated Polio Vaccine (IPV) - Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today its further commitment to the international community's efforts to complete polio eradication. UNICEF, the organization that procures the vaccine to meet global needs, announced...


Latest Vaccines Reference Libraries

72_d0e074525de5bb741daf382f8d62213f
2011-04-25 16:38:12

Neisseria meningitidis is a heterotrophic gram-negative diplococcal bacterium best known for its role in meningitis and other forms of meningococcal disease such as meningococcemia. It is a major cause of morbidity and mortality during childhood in industrialized countries and is responsible for epidemics in Africa and in Asia. In the US there are approximately 2500 to 3500 cases of N. meningitides infections. Children under 5 are at a higher risk as well as people in the sub-Saharan...

45_cbb742ff010fcfbfac5b5b73fd2e0254
2011-02-23 17:23:51

Poliovirus, the causative agent of poliomyelitis and a member of the family of Picornaviridae, is a human enterovirus. It is composed of an RNA genome that is a single-stranded positive-sense RNA. It was first isolate in 1909 and was published in 1981. It is one of the most well characterized viruses and has become a useful model system for understanding the biology of RNA viruses. It infects human cells by binding to an immunoglobulin-like receptor on the cell surface. The three...

More Articles (2 articles) »
Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.